Yummies (YUMM) 10-Q 11 Feb 22 2022 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Dec. 31, 2021	Jan. 28, 2022
Document Information Line Items
Entity Registrant Name	YUMMIES INC
Document Type	10-Q
Current Fiscal Year End Date	--09-30
Entity Common Stock, Shares Outstanding		449,626,500
Amendment Flag	false
Entity Central Index Key	0001073748
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Dec. 31, 2021
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	false
Entity Ex Transition Period	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-32361
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	87-0615629
Entity Address, Address Line One	6F., No.516, Sec. 1
Entity Address, Address Line Two	Neihu Road
Entity Address, Address Line Three	Neihu District
Entity Address, City or Town	Taipei City
Entity Address, Postal Zip Code	114
Entity Address, Country	TW
City Area Code	+88
Local Phone Number	6287511886
Entity Interactive Data Current	Yes

Condensed Consolidation Balance

Condensed Consolidation Balance Sheets - USD ($)	Dec. 31, 2021	Sep. 30, 2021
Current Assets:
Bank	$ 307	$ 579
Other receivables	11,199	11,119
Other receivables – related party	7,116	7,116
Total current assets	18,622	18,894
Total Assets	18,622	18,894
Current Liabilities:
Accounts payable
Notes payable, stockholders
Total net current liabilities
Stockholders’ Equity:
Common stock, $0.0001 par value, 450,000,000 shares authorized, 449,627,500 issued and outstanding as of December 31, 2021 and September 30, 2021	47,217	47,217
Preferred stock $0.0001 par value, 50,000,000 shares authorized, -0- and -0- issued and outstanding
Additional paid-in capital	235,816	224,950
Accumulated deficit	(264,411)	(253,273)
Total Stockholders’ Equity	18,622	18,894
Total Liabilities and Stockholders’ Equity	$ 18,622	$ 18,894

Condensed Consolidation Balan_2

Condensed Consolidation Balance Sheets (Parentheticals) - $ / shares	Dec. 31, 2021	Sep. 30, 2021
Statement of Financial Position [Abstract]
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	450,000,000	450,000,000
Common stock, shares issued	449,627,500	449,627,500
Common stock, shares outstanding	449,627,500	449,627,500
Preferred stock par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0

Condensed Consolidation Stateme

Condensed Consolidation Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Revenues – related party
Expenses, general and administrative	(11,138)	(3,432)
Operating loss	(11,138)	(3,432)
Other income (expense):
Interest expense		96
Loss before provision for income taxes	(11,138)	(3,336)
Provision for income taxes
Net loss	$ (11,138)	$ (3,336)
Net loss per share (in Dollars per share)
Weighted average shares outstanding (in Shares)	449,627,500	449,627,500

Consolidated Statements of Stoc

Consolidated Statements of Stockholders’ Equity - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Balance at Sep. 30, 2020	$ 47,217	$ 158,424	$ (192,312)
Balance (in Shares) at Sep. 30, 2020	449,626,500
Contribution by shareholder for company expenses paid directly by shareholder		66,526
Net loss for the year ended			(60,961)
Additional paid in capital
Balance at Sep. 30, 2021	$ 47,217	224,950	(253,273)
Balance (in Shares) at Sep. 30, 2021	449,626,500
Contribution by shareholder for company expenses paid directly by shareholder		10,866
Net loss for the year ended			(11,138)
Balance at Dec. 31, 2021	$ 47,217	$ 235,816	$ (264,411)
Balance (in Shares) at Dec. 31, 2021	449,626,500

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net loss	$ (11,138)	$ (3,336)
Adjustments to reconcile net loss to cash provided by operating activities:
Increase in account receivables – related party		(96)
Increase in account receivables
Increase in accounts payable
Net cash used in operating activities	(11,138)	(3,432)
Cash flows from investing activities
Cash flows from financing activities:
Contribution from a shareholder	10,866	4,000
Net cash generated from financing activities	10,866	4,000
Net decrease in cash	(272)	568
Cash, beginning of period	579	115
Cash, end of period	307	683
Supplemental disclosure of cash flow information:
Interest paid
Income taxes paid

Summary of Business and Signifi

Summary of Business and Significant Accounting Policies	3 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Summary of Business and Significant Accounting Policies	1. Summary of Business and Significant Accounting Policies a. Summary of Business The Company was incorporated under the laws of the State of Nevada on June 10, 1998 and commenced it business as consulting, training and event Management Company through its subsidiary. b. Basis of Presentation The accompanying financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) as promulgated in the United States of America. c. Cash Flows For purposes of the statement of cash flows, the Company considers all highly liquid investments purchased with a maturity of three months or less to be cash or cash equivalents. d. Net Loss Per Share The net loss per share calculation is based on the weighted average number of shares outstanding during the period. Net loss per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and potentially dilutive outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent share arrangements, stock options and warrants. There were no potentially dilutive common shares outstanding for the years ended December 31, 2021 and 2020. e. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. f. Fair Value of Financial Instruments ASC 820-10 requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practicable to estimate fair value. ASC 820-10 defines the fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. As of December 31, 2021 and 2020, the carrying value of certain financial instruments approximates fair value due to the short-term nature of such instruments. The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below: Level 1 - Quoted market prices available in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 - Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs). Level 3 - Unobservable inputs that reflect our assumptions about the assumptions that market participants would use in pricing the asset or liability. The Company’s financial instruments are consisted principally of accrued expenses and short term debt. The carrying amounts of such financial instruments in the accompanying balance sheets approximate their fair values due to their relatively short-term nature. g. Recently Issued Accounting Pronouncements In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business. In January 2017, the FASB issued ASU 2017-04, Intangibles—Goodwill and Other (Topic 350) In May 2017, the FASB issued ASU 2017-09, Compensation-Stock Compensation (Topic 718): Scope of Modification Accounting. In July 2017, the FASB issued ASU 2017-11, Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception Earnings Per Share h. Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Yummies, SG. All significant intercompany transactions and balances have been eliminated. i. Related Party Revenue and Accounts Receivable There was no revenue generated from the Company during the period ended December 31, 2021 and 2020. The total amount earned is an account receivable at year end and remains uncollected as of the audit date.

Risks and Uncertainties

Risks and Uncertainties	3 Months Ended
	Dec. 31, 2021
Risks and Uncertainties [Abstract]
Risks and Uncertainties	2. Risks and Uncertainties In December 2019, a novel strain of coronavirus (COVID-19) emerged in Wuhan, Hubei Province, China. While initially the outbreak was largely concentrated in China and caused significant disruptions to its economy, it has now spread to several other countries and infections have been reported globally. Because COVID-19 infections have been reported throughout the United States, certain federal, state and local governmental authorities have issued stay-at-home orders, proclamations and/or directives aimed at minimizing the spread of COVID-19. Additional, more restrictive proclamations and/or directives may be issued in the future. As a result, all of our offices have been closed effective April 1, 2020. The ultimate impact of the COVID-19 pandemic on the Company’s operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, reduced customer traffic and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time but is anticipated to have a material adverse impact on our business, financial condition and results of operations. The measures taken to date will impact the Company’s business for the fiscal third quarter and potentially beyond. Management expects that all of its business segments, across all of its geographies, will be impacted to some degree, but the significance of the impact of the COVID-19 outbreak on the Company’s business and the duration for which it may have an impact cannot be determined at this time.

Issuance of Common Stock

Issuance of Common Stock	3 Months Ended
	Dec. 31, 2021
Stockholders' Equity Note [Abstract]
Issuance of Common Stock	3. Issuance of Common Stock On December 17, 2018, the Company amended and restated its articles of incorporation. The authorized shares of common stock were increased from 50,000,000 shares to 450,000,000 shares and the par value was changed from $0.001 to $0.0001 per share. The change has been reflected retroactively in the accompanying financial statements. In addition, the Company authorized the issuance of 50,000,000 shares of preferred stock having a par value of $0.0001 per share. As of December 31, 2020, no preferred shares have been issued. In February 2019, pursuant to an exemption from the registration requirements of the Securities Act of 1933, as amended, (the “Securities Act”) provided by Section 4(a)(2) and Regulation S thereunder, the Company sold 446,472,607 shares of its common stock at a price of $0.0001 per share for an aggregate price of $44,647. Issuance costs of $45,725 were offset against additional paid in capital in the accompanying financial statements. In October, 2019, the Company issued 3,527,393 shares of its $.0001 par value common stock for an aggregate price of $352.74. In August 2020, the Company issued 121,500 shares of its $.0001 par value common stock for an aggregate price of $12.15.

Warrants and Stock Options

Warrants and Stock Options	3 Months Ended
	Dec. 31, 2021
Warrants And Stock Options [Abstract]
Warrants and Stock Options	4. Warrants and Stock Options No options or warrants are outstanding to acquire the Company’s common stock.

Income Taxes

Income Taxes	3 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Income Taxes	5. Income Taxes The Company has no taxable income under Federal or State tax laws. The Company has loss carry forwards totaling $264,411 during the three-month period ended December 31, 2021 that may be offset against future federal income taxes. If not used, the carry forwards will expire between 2021 and 2038. Due to the Company being in the development stage and incurring net operating losses, a valuation allowance has been provided to reduce the deferred tax assets from the net operating losses to zero. Therefore, there are no tax benefits recognized in the accompanying statement of operations. The income tax effect of the Tax Cuts and Jobs Act have been completed in accordance with FASB ASC740.

Going Concern

Going Concern	3 Months Ended
	Dec. 31, 2021
Going Concern [Abstract]
Going Concern	6. Going Concern As shown in the accompanying financial statements, the Company incurred a net loss of $11,138 during the three months ended December 31, 2021 and accumulated losses of $264,411 since inception at June 10, 1998

Subsequent Events

Subsequent Events	3 Months Ended
	Dec. 31, 2021
Subsequent Events [Abstract]
Subsequent Events	7. Subsequent Events Management has evaluated subsequent events through January 28, 2022, the date on which the financial statements were available to be issued.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	3 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Summary of Business	a. Summary of Business The Company was incorporated under the laws of the State of Nevada on June 10, 1998 and commenced it business as consulting, training and event Management Company through its subsidiary.
Basis of Presentation	b. Basis of Presentation The accompanying financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) as promulgated in the United States of America.
Cash Flows	c. Cash Flows For purposes of the statement of cash flows, the Company considers all highly liquid investments purchased with a maturity of three months or less to be cash or cash equivalents.
Net Loss Per Share	d. Net Loss Per Share The net loss per share calculation is based on the weighted average number of shares outstanding during the period. Net loss per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and potentially dilutive outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent share arrangements, stock options and warrants. There were no potentially dilutive common shares outstanding for the years ended December 31, 2021 and 2020.
Use of Estimates	e. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.
Fair Value of Financial Instruments	f. Fair Value of Financial Instruments ASC 820-10 requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practicable to estimate fair value. ASC 820-10 defines the fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. As of December 31, 2021 and 2020, the carrying value of certain financial instruments approximates fair value due to the short-term nature of such instruments. The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below: Level 1 - Quoted market prices available in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 - Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs). Level 3 - Unobservable inputs that reflect our assumptions about the assumptions that market participants would use in pricing the asset or liability. The Company’s financial instruments are consisted principally of accrued expenses and short term debt. The carrying amounts of such financial instruments in the accompanying balance sheets approximate their fair values due to their relatively short-term nature. g. Recently Issued Accounting Pronouncements
Recently Issued Accounting Pronouncements	g. Recently Issued Accounting Pronouncements In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business. In January 2017, the FASB issued ASU 2017-04, Intangibles—Goodwill and Other (Topic 350) In May 2017, the FASB issued ASU 2017-09, Compensation-Stock Compensation (Topic 718): Scope of Modification Accounting. In July 2017, the FASB issued ASU 2017-11, Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception Earnings Per Share
Principles of Consolidation	h. Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Yummies, SG. All significant intercompany transactions and balances have been eliminated.
Related Party Revenue and Accounts Receivable	i. Related Party Revenue and Accounts Receivable There was no revenue generated from the Company during the period ended December 31, 2021 and 2020. The total amount earned is an account receivable at year end and remains uncollected as of the audit date.

Issuance of Common Stock (Detai

Issuance of Common Stock (Details) - USD ($)	1 Months Ended
	Aug. 31, 2020	Oct. 31, 2019	Feb. 28, 2019	Dec. 31, 2021	Sep. 30, 2021	Dec. 17, 2018
Issuance of Common Stock (Details) [Line Items]
Common stock, shares authorized				450,000,000	450,000,000
Common stock, par value	$ 1	$ 1		$ 0.0001	$ 0.0001
Preferred stock, shares authorized				50,000,000	50,000,000
Preferred stock, par value				$ 0.0001	$ 0.0001
Number of common stock sold			446,472,607
Common stock price per share			$ 0.0001
Aggregate price	$ 12.15	$ 352.74	$ 44,647
Issuance costs of were offset against additional paid in capital			$ 45,725
Common stock, shares issued	121,500	3,527,393
Minimum [Member]
Issuance of Common Stock (Details) [Line Items]
Common stock, shares authorized						50,000,000
Common stock, par value						$ 0.001
Maximum [Member]
Issuance of Common Stock (Details) [Line Items]
Common stock, shares authorized						450,000,000
Common stock, par value						$ 0.0001

Income Taxes (Details)

Income Taxes (Details)	3 Months Ended
	Dec. 31, 2021USD ($)
Income Tax Disclosure [Abstract]
Loss carry forwards	$ 264,411
Description of carry forwards expiration	the carry forwards will expire between 2021 and 2038.
Net operating losses	$ 0

Going Concern (Details)

Going Concern (Details) - USD ($)	3 Months Ended
	Dec. 31, 2021	Sep. 30, 2021
Going Concern [Abstract]
Net loss	$ 11,138
Accumulated losses	(264,411)	$ (253,273)
Current assets exceed its current liabilities	$ 18,622